MELIUS

Trademark usage description

medicines for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; p Read More

Classification Information

Class [005]
Medicines for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of mental health disorders

Classification kind code

Class [042]
Clinical trials; conducting interventional clinical studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research in the fields of clinical trials and post-market trials; scientific research for the development of CRISPR-based platforms and products in the field of genetic engineering

Classification kind code

Mark Details

Serial Number

2243514

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 1^st Jan 2025	Advertised
Submitted for opposition 26 on 3^rd Dec 2024	Approved
Submitted for opposition 27 on 3^rd Dec 2024	Approval Notice Sent
Submitted for opposition 22 on 19^th Jun 2024	Search Recorded
Submitted for opposition 20 on 19^th Jun 2024	Examiner's First Report
Submitted for opposition 48 on 2^th Aug 2023	Agent Changed
Submitted for opposition 30 on 6^th Mar 2023	Filed
Submitted for opposition 1 on 6^th Mar 2023	Created
Submitted for opposition 31 on 6^th Mar 2023	Formalized